|
Group
|
Systolic BP
|
|---|
|
Day 0
|
Day 5
|
Day 10
|
Day 15
|
|---|
|
DF66
|
118.66 + 4.8
|
185.16 + 6.68
|
161 + 9.25
|
151.58 + 4.02
|
|
CAP20
|
108.41+ 2.45
|
98.66 + 4.81 b3c3d3e3
|
96.33 + 7.91 b3c1
|
93.00 + 5.31 b3
|
|
OI250
|
116.16+ 3.49
|
150.66 + 8.79 a2
|
135 + 13.17
|
109.75 + 11.64 a3
|
|
OI500
|
121.91+ 4.76
|
140 + 6.26 a3
|
87.08 + 9.24 a3 f2
|
109.33 + 3.08 a3
|
|
OI1000
|
110.25+ 6.13
|
142.41 + 3.17a3
|
96.91 + 4.51 a3 f1
|
102.91 + 4.17 a3
|
- Data are expressed as mean ± SEM (n = 6); Analysis was performed by one-way ANOVA; a, DF66 vs OI; b, DF66 vs CAP20; c, OI250 vs CAP20; d, OI500 vs CAP20; e, OI1000 vs CAP20; f, OI250 vs OI500 and OI100; DF66 Rats with 66% fructose ingestion, CAP20 Captopril 20 mg/kg, OI Otostegia integrifolia at doses of 250, 500 and 1000 mg/kg; 1p < 0.05; 2p < 0.01; 3p < 0.001.
